Company Search:
Advanced Search
Sponsored Links
Eli Lilly and Company Company Snapshot
Eli Lilly and Company operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other companies in this sector in the United States: Teva Pharmaceutical Industries Limited (2018 sales of $18.85 billion of which 49% was North America), AstraZeneca PLC ($22.09 billion of which 100% was Pharmaceuticals), and Bristol-Myers Squibb Company ($22.56 billion of which 100% was BioPharmaceuticals).

Sales Analysis. Eli Lilly and Company reported sales of $24.56 billion for the year ending December of 2018. This represents an increase of 7.4% versus 2017, when the company's sales were $22.87 billion. This was the fourth straight year of sales growth at Eli Lilly and Company. The sales level in 2018 was fairly close to the level five years ago: in 2013, Eli Lilly and Company had sales of $23.11 billion. Sales of Human Pharmaceutical Products-Immunology saw an increase that was more than double the company's growth rate: sales were up 88.4% in 2018, from $605.10 million to $1.14 billion. Eli Lilly and Company also saw significant increases in sales in Human Pharmaceutical Products - Endocrin (up 16.0% to $11.70 billion) and Human Pharmaceutical Products-Oncology (up 11.8% to $4.26 billion) . Not all segments of Eli Lilly and Company experienced an increase in sales in 2018: sales of Human Pharmaceutical Products - Cardiova fell 21.5% to $2.25 billion. Eli Lilly and Company also experienced decreases in sales in Human Pharmaceutical Products -Neuroscie (down 16.1% to $1.82 billion) and Other Pharmaceuticals (down 2.5% to $235.30 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eli Lilly and Company
  Stock Performance Chart for Eli Lilly and Company
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2020): 138.00
(Figures in U.S. Dollars)
1 Week 4.7%   13 Weeks 13.6%  
4 Weeks 27.4%   52 Weeks 18.8%  
Eli Lilly and Company Key Data:
  Ticker: LLY Country: United States
  Exchanges: NYSE FRA LON MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 24,555,700,000
(Year Ending Jan 2019).
Employees: 38,680
  Currency: U.S. Dollars Market Cap: 132,498,046,398
  Fiscal Yr Ends: December Shares Outstanding: 960,130,771
  Share Type: Common Closely Held Shares: 1,969,587
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.